Welcome to the virtual stand of Amgen Inc.
Take a look around and feel free to contact us.
Would you also like to see the HCP relevant content? Please log in here with your DocCheck data:
You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationWelcome to the virtual stand of Amgen Inc.
Take a look around and feel free to contact us.
Would you also like to see the HCP relevant content? Please log in here with your DocCheck data:
You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationBiomanufacturing der Zukunft – Amgen
You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationAs one of the leading biotechnology companies, we set new standards in the production of biotechnological drugs. For us, biomanufacturing of the future means making processes more sustainable and efficient.
Our modern production facilities combine the latest technologies in plants that are 75% smaller than conventional facilities - while maintaining the same production capacity.
By modernizing our manufacturing process, we can work more flexibly and environmentally friendly and make our products available more quickly.
Product 2
This area is DocCheck protected. Please log in here.
Download Section
This area is DocCheck protected. Please log in here.
Über Amgen
You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationAmgen ist ein global führendes unabhängiges Biotechnologie-Unternehmen, das mit etwa 24.000 Mitarbeitenden in fast 100 Ländern seit über 40 Jahren vertreten ist. In Deutschland arbeiten wir an zwei Standorten mit rund 850 Mitarbeitenden jeden Tag daran, Patient:innen zu helfen. Weltweit profitieren jährlich Millionen von Menschen mit schweren oder seltenen Erkrankungen von unseren Therapien. Unsere Arzneimittel werden in der Nephrologie, Kardiologie, Hämatologie, Onkologie, Knochengesundheit und bei chronisch-entzündlichen Erkrankungen eingesetzt. Neben Originalpräparaten beinhaltet unser Portfolio auch Biosimilars.
Wir verfügen über eine vielfältige Pipeline.
www.amgen.de
